ASSESSMENT OF LIVER FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING ERTUGLIFLOZIN

被引：0
|
作者：
Gallo, Silvina [1 ]
Calle, Roberto [2 ]
Terra, Steven [2 ]
Pong, Annpey [3 ]
Tarasenko, Lisa [2 ]
Raji, Annaswamy [3 ]
机构：
[1] Pfizer Pharma Gmbh, Berlin, Germany
[2] Pfizer Inc, New York, NY USA
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2129
引用
收藏
页码：1261A / 1261A
页数：1
相关论文
共 50 条
  • [41] ASSESSMENT OF ATHEROTHROMBOTIC RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Berg, David
    Moura, Filipe A.
    Tang, Minao
    Scirica, Benjamin M.
    Wiviott, Stephen
    Morrow, David A.
    Bhatt, Deepak L.
    Raz, Itamar
    Bohula, Erin Ann
    Giugliano, Robert P.
    Park, Jeong-Gun
    Feinberg, Mark William
    Braunwald, Eugene
    Sabatine, Marc Steven
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 962 - 962
  • [42] Assessment of bone remodeling in patients with type 2 diabetes mellitus
    Safarova, S. S.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2019, (01) : 60 - 63
  • [43] Assessment of Cardiovascular Risks in Patients with Diabetes Mellitus Type 2
    Mehdiyev, S. Kh.
    Mustafayev, I. I.
    Gasimova, F. N.
    Mamedov, M. N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C223 - C224
  • [44] The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
    Sahasrabudhe, V.
    Terra, S. G.
    Hickman, A.
    Saur, D.
    Shi, H.
    O'Gorman, M.
    Zhou, Z.
    Cutler, D. L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1432 - 1443
  • [45] The effect of renal impairment on the pharmacokinetics and pharmacodynamics of ertugliflozin in subjects with type 2 diabetes mellitus
    Sahasrabudhe, V.
    Terra, S. G.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Matschke, K.
    Shi, H.
    O'Gorman, M.
    Chakravarthy, M. V.
    Cutler, D. L.
    [J]. DIABETOLOGIA, 2015, 58 : S359 - S359
  • [46] Self-Assessment and Determination of Dexterity and Cognitive Function in Patients with Type 1 and Type 2 Diabetes Mellitus
    Musholt, Petra
    Schipper, Christina
    Niemeyer, Marcus
    Qvist, Marianne
    Schorsch, Andrea
    Forst, Thomas
    Pfuetzner, Andreas
    [J]. DIABETES, 2011, 60 : A592 - A592
  • [47] Population Pharmacokinetic (POPPK) Model for Ertugliflozin in Healthy Subjects and Type 2 Diabetes Mellitus (T2DM) Patients
    Fediuk, Daryl J.
    Sweeney, Kevin
    Zhou, Susan
    Kumar, Vikas
    Sahasrabudhe, Vaishali
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S25 - S25
  • [48] Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
    David Z. I. Cherney
    Bernard Charbonnel
    Francesco Cosentino
    Samuel Dagogo-Jack
    Darren K. McGuire
    Richard Pratley
    Weichung J. Shih
    Robert Frederich
    Mario Maldonado
    Annpey Pong
    Christopher P. Cannon
    [J]. Diabetologia, 2021, 64 : 1256 - 1267
  • [49] Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus
    Hardt, PD
    Krauss, A
    Bretz, L
    Porsch-Özcürümez, M
    Schnell-Kretschmer, H
    Mäser, E
    Bretzel, RG
    Zekorn, T
    Klör, HU
    [J]. ACTA DIABETOLOGICA, 2000, 37 (03) : 105 - 110
  • [50] Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus
    P.D. Hardt
    A. Krauss
    L. Bretz
    M. Porsch-Özcürümez
    H. Schnell-Kretschmer
    E. Mäser
    R.G. Bretzel
    T. Zekorn
    H.U. Klör
    [J]. Acta Diabetologica, 2000, 37 : 105 - 110
12345